Instylla Inc.March 30, 2021Instylla Announces Enrollment of Initial Patients in the Embrace™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial
Saphena MedicalJanuary 5, 2021Saphena Medical’s Venapax® EVH System Awarded Sole Supplier Contract With Premier® Inc.’s SURPASS™ Purchasing Program
Saphena MedicalDecember 7, 2020Saphena Medical’s Venapax® EVH System Awarded Sole-Supplier Contract With Premier Inc.’s ASCEND Purchasing Program
ConformalOctober 16, 2020Conformal Medical’s CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference
ConformalOctober 15, 2020Novel Conformable Foam-Based Implant for Left Atrial Appendage Closure: Conformable EFS Experience
AtaCor MedicalApril 28, 2020AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
Sera PrognosticsFebruary 24, 2020Sera Prognostics to Present at the 40th Annual Cowen Health Care Conference
ConformalJanuary 22, 2020Conformal Medical Announces First Left Atrial Appendage Closures Performed Under Conscious Sedation with its CLAAS Technology at AF Symposium 2020
Sera PrognosticsJanuary 9, 2020Sera Prognostics to Present at the 38th Annual JP Morgan Healthcare Conference
